Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4915 in Primary Sjogren's Disease
NCT07823790Phase 2Not yet recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2026
- Primary completion
- Feb 2029
01
Overview
A Phase 2 trial of ONO-4915 in Sjögren's syndrome, sponsored by Ono Pharmaceutical. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ONO-4915
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT07823790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07823790.